Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris. (Q43408664)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Dagmar Wilsmann-Theis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Kristina Fronhoffs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Lin-Kristin Ehler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Thomas Bieber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Karin Klingmueller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

2 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

55-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

Psoriasis: What is new in nonbiologic systemic therapy in the era of biologics?

7 March 2020

cites work

1 reference

Combination systemic therapies in psoriatic arthritis

21 January 2018

1 reference

Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial

21 January 2018

1 reference

Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre.

21 January 2018

1 reference

Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.

21 January 2018

1 reference

The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.

21 January 2018

1 reference

Psoriasis, the liver, and the gastrointestinal tract

21 January 2018

1 reference

Systemic combination treatment for psoriasis: a review.

21 January 2018

1 reference

Dealing with immunogenicity of biologicals: assessment and clinical relevance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/DTH.12046

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24502314%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference